IDH1 and glioblastoma: Additionally, microvascular proliferation, Tert promoter mutations, Egfr amplification, or Pten loss (analogous to monosomy 10 in humans) – which are included as essential diagnostic criteria for WHO CNS grade 4 IDH-wildtype glioblastoma – were not observed in either model.